Recent Advances in Material Technology for Leukemia Treatments

Area of Science:

• Hematology
• Biomaterials Science
• Oncology

Background:

• Leukemia, a hematological malignancy, often results in treatment failure, particularly for acute leukemia patients, necessitating optimized therapeutic strategies.
• Despite clinical advancements, achieving long-term or complete remission remains a challenge for many leukemia patients.
• Novel therapeutic approaches are crucial to improve patient outcomes in leukemia treatment.

Purpose of the Study:

• To provide a comprehensive overview of various materials being investigated for leukemia therapy.
• To describe the physicochemical properties and therapeutic roles of these materials in different treatment modalities.
• To highlight the challenges associated with the clinical translation of these novel materials.

Main Methods:

• Literature review of recent studies on materials used in leukemia treatment.
• Analysis of the application of diverse materials (liposomes, protein-based, polymeric, cell-derived, inorganic) in various therapeutic modalities.
• Examination of material properties, therapeutic efficacy, and clinical translation challenges.

Main Results:

• Various materials including liposomes, protein-based, polymeric, cell-derived, and inorganic substances are being explored as delivery vectors and direct agents.
• These materials are applied across multiple therapeutic modalities such as chemotherapy, gene therapy, immunotherapy, and radiotherapy.
• Key physicochemical properties and roles in leukemia intervention have been detailed for each material class.

Conclusions:

• Diverse materials offer potential to enhance the efficacy of existing and evolving leukemia therapies.
• Further research and development are needed to overcome clinical translation challenges for these novel materials.
• This review aims to inspire further innovation in material-based therapeutic strategies for leukemia.